Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of June 2025. The report details the status of the Company's Annual General Meeting of Shareholders convened on June 23, 2025.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report regarding a shareholder meeting and contains no financial statements.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing.
Guidance, Outlook, and Management Commentary
The Company convened its Annual General Meeting on June 23, 2025. However, the meeting was adjourned for one week due to a lack of quorum. The meeting is scheduled to be reconvened on Monday, June 30, 2025, at 3:00 p.m. Israel time at the Company's offices in Ramat Gan, Israel.
Key Facts for Investor Verification
- The Annual General Meeting originally scheduled for June 23, 2025, failed to achieve a quorum.
- The meeting has been rescheduled for June 30, 2025.
- This filing contains no financial performance data or updated business outlook.